Example: Heart Attack

Search clinical trials for: Entacapone

Total 55 results

NCT04006769

Not yet recruiting

Entacapone Combination With Imatinib for Treatment of GIST

Conditions: Gastrointestinal Stromal Tumor, Malignant
NCT02349243

Unknown status

Effect of Entacapone on Bodyweight Loss in Obese Population

Conditions: Obesity
NCT00373087

Completed

COMT Polymorphism and Entacapone Efficacy

Conditions: Parkinson's Disease
NCT00192855

Completed

Entacapone Augmentation for Schizophrenia

Conditions: Schizophrenia
NCT02058966

Completed

Pilot Study of Entacapone for Methamphetamine Abuse

Conditions: Methamphetamine Dependence
NCT01437293

Completed

Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)

Conditions: Cocaine Abuse
NCT00237263

Completed

An Extension Study of Entacapone in Patients With Parkinson's Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States

Conditions: Parkinson's Disease
NCT00391898

Completed

Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

Conditions: Parkinson's Disease
NCT00219284

Completed

Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

Conditions: Parkinson's Disease With End of Dose Wearing Off
NCT00642356

Terminated

Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

Conditions: Parkinson's Disease
NCT00099268

Completed

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

Conditions: Parkinson's Disease
NCT00547911

Terminated

Augmenting Effects of L-DOPS With Carbidopa and Entacapone

Conditions: Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System Diseases
NCT00601978

Withdrawn

Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

Conditions: Parkinson's Disease
NCT00415831

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Conditions: Healthy
NCT00415740

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Conditions: Healthy
NCT00143026

Completed

Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

Conditions: Parkinson's Disease
NCT00415922

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

Conditions: Healthy
NCT00415844

Completed

Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers

Conditions: Healthy
NCT00134966

Completed

A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

Conditions: Parkinson's Disease
NCT02452606

Unknown status

Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

Conditions: Parkinson Disease; Sleep Disorders
NCT00247247

Completed

Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

Conditions: Parkinson's Disease
NCT01840423

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers

Conditions: Healthy
NCT01130493

Completed

A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

Conditions: Parkinson's Disease
NCT01468012

Completed

Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

Conditions: Cocaine Dependence
NCT00906828

Completed

Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

Conditions: Parkinson Disease